<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>The Neuroscience Journal of Shefaye Khatam</title>
<title_fa>مجله علوم اعصاب شفای خاتم</title_fa>
<short_title>Shefaye Khatam</short_title>
<subject>Medical Sciences</subject>
<web_url>http://shefayekhatam.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2322-1887</journal_id_issn>
<journal_id_issn_online>2345-4814</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/shefa</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>fa</language>
<pubdate>
	<type>jalali</type>
	<year>1393</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2014</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<volume>2</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>fa</language>
	<article_id_doi></article_id_doi>
	<title_fa>P58: Neurological Outcomes after Traumatic Brain Injury Affected by Concomitant Administration of Progesterone and Erythropoietin</title_fa>
	<title>P58: Neurological Outcomes after Traumatic Brain Injury Affected by Concomitant Administration of Progesterone and Erythropoietin</title>
	<subject_fa>نوروفارماکولوژی</subject_fa>
	<subject>Neuropharmacology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research --- Open Access, CC-BY-NC</content_type>
	<abstract_fa>&lt;p align=&quot;center&quot;&gt;لطفاً به چکیده انگلیسی مراجعه شود. &lt;/p&gt;</abstract_fa>
	<abstract>Traumatic brain injury (TBI) is one of the most common neurological diseases with no definite treatment. Erythropoietin (Epo) and progesterone (Prog) have been shown to have neuroprotective effects in different types of experimental brain injury models. This study was designed to determine the effect of Epo, Prog and combination of Epo/Prog on neurological outcome after traumatic brain injury. Fifty-four male Wistar rats were divided into 5 groups including intact (n=6), TBI (n=12), TBI + 16 mg/kg Prog (n=12), TBI + 5000 U/kg Epo (n=12), TBI + 16 mg/kg Pro + 5000 U/kg Epo (n=12). Neurological evaluation was performed using modified Neurological Severity Score on days 1, 2, 7 and 14 post TBI. The results revealed that Prog and Epo individually ameliorated neurological deficit following TBI while the combination of Prog and Epo exacerbated the neurological dysfunction. In conclusion, our study indicates that the combination of Prog and Epo does not improve neurologic outcome after TBI.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Traumatic Brain Injury, Progesterone, Neuroprotective</keyword>
	<start_page>108</start_page>
	<end_page>108</end_page>
	<web_url>http://shefayekhatam.ir/browse.php?a_code=A-10-24-455&amp;slc_lang=fa&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Zahra </first_name>
	<middle_name></middle_name>
	<last_name>Nourzad</last_name>
	<suffix></suffix>
	<first_name_fa>Zahra </first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Nourzad</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846006202</code>
	<orcid>10031947532846006202</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran.</affiliation>
	<affiliation_fa>Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran.</affiliation_fa>
	 </author>


	<author>
	<first_name>Tahere </first_name>
	<middle_name></middle_name>
	<last_name>Ghadiri</last_name>
	<suffix></suffix>
	<first_name_fa>Tahere </first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Ghadiri</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846006203</code>
	<orcid>10031947532846006203</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran.</affiliation>
	<affiliation_fa>Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran.</affiliation_fa>
	 </author>


	<author>
	<first_name>Arezou </first_name>
	<middle_name></middle_name>
	<last_name>Eshaghabadi</last_name>
	<suffix></suffix>
	<first_name_fa>Arezou </first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Eshaghabadi</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846006204</code>
	<orcid>10031947532846006204</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran.</affiliation>
	<affiliation_fa>Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran.</affiliation_fa>
	 </author>


	<author>
	<first_name>Mostafa </first_name>
	<middle_name></middle_name>
	<last_name>Modarres  Mousavi</last_name>
	<suffix></suffix>
	<first_name_fa>Mostafa </first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Modarres  Mousavi</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>modarres.mousavi@gmail.com	</email>
	<code>10031947532846006205</code>
	<orcid>10031947532846006205</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran.</affiliation>
	<affiliation_fa>Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran.</affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
